Bulk Pharmaceuticals Task Force
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2020 | 98,472 | 55,646 | 42,826 | 13.2 | — |
| 2021 | 99,083 | 69,603 | 29,480 | 15.7 | — |
| 2022 | 61,155 | 62,590 | −1,435 | 17.1 | — |
| 2023 | 82,992 | 71,542 | 11,450 | 16.9 | — |
In its most recent public year (2023), this organization brought in $11,450 more than it spent. Its reserves stood at about 16.9 months of spending, up from 13.2 in 2020.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Bulk Pharmaceuticals Task Force's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works